EBA
ABBV icon

Eagle Bay Advisors’s AbbVie ABBV Stock Holding History

Eagle Bay Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Buy
8,231
+112
+1% +$24.8K 1.58% 17
2025
Q4 		$1.86M Sell
8,119
-409
-5% -$93.2K 1.35% 15
2025
Q3 		$1.97M Sell
8,528
-906
-10% -$184K 1.55% 14
2025
Q2 		$1.75M Sell
9,434
-48
-0.5% -$8.92K 1.45% 15
2025
Q1 		$1.99M Sell
9,482
-33
-0.3% -$6.42K 1.68% 14
2024
Q4 		$1.69M Sell
9,515
-206
-2% -$37.9K 1.06% 18
2024
Q3 		$1.92M Buy
9,721
+7
+0.1% +$1.31K 0.74% 28
2024
Q2 		$1.67M Buy
9,714
+378
+4% +$62.6K 1.01% 19
2024
Q1 		$1.7M Sell
9,336
-534
-5% -$92K 1.07% 19
2023
Q4 		$1.53M Sell
9,870
-385
-4% -$56.1K 0.97% 22
2023
Q3 		$1.53M Buy
10,255
+441
+4% +$64.7K 0.71% 31
2023
Q2 		$1.32M Sell
9,814
-22
-0.2% -$3.23K 0.76% 31
2023
Q1 		$1.57M Sell
9,836
-429
-4% -$65.6K 0.86% 26
2022
Q4 		$1.66M Sell
10,265
-1,233
-11% -$189K 0.93% 24
2022
Q3 		$1.54M Sell
11,498
-292
-2% -$41.9K 0.95% 21
2022
Q2 		$1.81M Buy
11,790
+329
+3% +$50.3K 1.09% 16
2022
Q1 		$1.86M Buy
11,461
+128
+1% +$18.6K 1.52% 13
2021
Q4 		$1.53M Sell
11,333
-2,476
-18% -$292K 0.98% 16
2021
Q3 		$1.49M Buy
13,809
+2,171
+19% +$248K 0.84% 20
2021
Q2 		$1.32M Buy
+11,638
New +$1.31M 1.07% 17

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eagle Bay Advisors's ABBV Position: Q1 2026 in Review

Eagle Bay Advisors increased its AbbVie (ABBV) stake by 1.4% in Q1 2026, buying an estimated $24.8K and bringing the position to 8,231 shares worth $1.79M. The position accounts for 1.58% of the portfolio, ranked #17.

Eagle Bay Advisors first reported a position in ABBV in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.99M in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Eagle Bay Advisors held 8,231 shares of AbbVie worth $1.79M as of Q1 2026.
  • Eagle Bay Advisors bought 112 AbbVie shares in Q1 2026, an estimated $24.8K.
  • AbbVie made up 1.58% of Eagle Bay Advisors's portfolio in Q1 2026, its #17 holding.
  • Eagle Bay Advisors first reported a position in AbbVie in Q2 2021 and has held it in 20 quarters since.
  • Eagle Bay Advisors's AbbVie position peaked at $1.99M in Q1 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.